FDA Investigator Thomas J Mooney
Thomas J Mooney has inspections in 1 countries as of 31 Oct 2023. Thomas J Mooney has collaborated with a combined 2544 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
175
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alice S Tsao,
Althea A Williams,
Amatul H Marium,
Amber D Brodas,
Amy W Mai,
Amy W Yan Mai,
Andrew F Cohen,
Andrew J Garufi,
Andrew M Abramowitz,
Ann B Okon,
Ann M Stewart,
Arduino Frankovic,
Arthur G Hurst,
Avital A Shimanovich,
Betty M Ng Lee,
Bijoy Panicker,
Brandy N Lepage,
Brian M Brodman,
Brian S Keefer,
Carr,
Carrie E Jolly,
Cary Greene,
Charanjeet Jassal,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher S Fields,
Daniel L Zheng,
Daniel T Lee,
Daniel W Johnson,
Danna E Solorzano,
Dave M Deroche,
David R Delucia,
Deborah J Parris,
Demitria J Xiradakis,
Dilijeta Bajrami,
Dipesh K Shah,
Donald J Ullstrom,
Dongping Dai, PhD,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Edouard Viard,
Eric J Reisenauer,
Erica B Raphael,
Erik W Koester,
Evelyn Taha,
Felix Maldonado,
Frank Verni,
Gam S Zamil,
Gary J Lehr,
Gary T Greco,
Gray,
Gregson A Joseph,
Guerlain Ulysse,
Helen B Ricalde,
Ilana Zigelman,
Iram R Hassan, PhD,
Jacqueline S Warner,
James A Liubicich,
Jana J Lau,
Jane Chen,
Jason D Tenney,
Jay T Wong,
Jazmine N Brown,
Jazmine N Still,
Jeffrey J Thibodeau,
Jogy George,
Jose O Hernandez,
Jose Ohernandez Guzman,
Joseph Duca,
Joseph Maselli,
Joseph Milcetic,
Joy P Matthias,
Juan Rjimenez Garcia,
Juanita P Versace,
Judy Friedman,
Juliana Falla,
Justin A Boyd,
Karen L Kosar,
Karishma G Gopaul,
Kenneth H Williams,
Kevin A Gonzalez,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kwong Lee,
Kwong P Lee,
Lawrence W Farina,
Marie Bbuen Bigornia,
Melissa N Gregorio,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael G Sinkevich,
Michael R Dominick,
Mindy M Chou,
Nada F Agabani,
Nariman Patenaude,
Nazmul Hassan,
Neil J Bonzagni, PhD MPH,
Nerizza B Guerin,
Nicole Vaught,
Otto D Vitillo,
Parul M Patel,
Patrick C Klotzbuecher,
Paul E Stein,
Paul Mouris,
Perez,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Philip F Istafanos, DMV, MS,
Phyllis J Wilson,
Rachael A Moliver,
Raymond M Lam,
Robert C Howard,
Robert C Steyert,
Robert E Moncayo,
Robert J Veitch,
Ronald Ifraimov,
Samina S Khan,
Samuel T Walker,
Sarah A Meehan,
Sarah A Wangseng,
Satheesh Thomas,
Shantelle I Hughes,
Shari L Kahn,
Shreya Shah,
Simone E Pitts,
Smith,
Sony Mathews,
Sou Chan Chang,
State Agency,
Stephanie T Durso,
Steven M Weinman,
Sunita Vij,
Susan M Joseph,
Susant Hadman,
Syeda N Mahazabin,
Tanya R Syffrard,
Tara K Normandin,
Terry Bridgewater,
Thomas E Friel,
Thomas J Mccrey,
Tiffany S Allison,
Tracy M Portelli,
Uduak M Inokon,
Valerie A Potopsingh,
Wai H Lam,
Wayne J Meyer,
Wayne S Fortenberry,
Yuyan Liang,
Yvonne M Santiago
Thomas J Mooney's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2004 | EIR | NBTY Inc. - EIR, 2004-02-17 |
February, 2009 | EIR | Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2009-02-05 |
April, 2000 | EIR | NBTY, Inc. - EIR, 2000-04-06 |
October, 2003 | EIR | Amneal Pharmaceuticals of New York, LLC - EIR, 2003-10-10 |
July, 2006 | EIR | Advance Pharmaceutical, Inc. - EIR, 2006-07-26 |
January, 2003 | EIR | Corwood Labs Inc - EIR, 2003-01-29 |
September, 2003 | FDA 483 | PDK Labs, Inc - Form 483, 2003-09-22 |
May, 2003 | EIR | Contract Pharmacal Corporation - EIR, 2003-05-08 |
February, 2006 | EIR | LNK International, Inc. - EIR, 2006-02-16 |
July, 2002 | FDA 483 | Altaire Pharmaceuticals Inc. - Form 483, 2002-07-25 |
February, 2006 | EIR | LNK International, Inc. - EIR, 2006-08-30 |
March, 2007 | FDA 483 | Pharbest Pharmaceuticals, Inc. - Form 483, 2007-03-08 |
February, 2006 | FDA 483 | LNK International, Inc. - Form 483, 2006-02-16 |
May, 2003 | EIR | Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2003-05-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more